Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
Avatar

Lynch Syndrome and Gynecologic Cancer Risk (and Risk Reduction)

By Dana-Farber Cancer Institute FEATURING Marcela G. del Carmen
January 5, 2019
1 Comment
Login to view comments. Click here to Login

Featured Video

15:18
Treatment Considerations in CLL: Challenging Patient Cases

Treatment Considerations for Ibrutinib-Intolerant Patients - A Patie…

Feat. M. Shadman

Featured Video

18:47
Treatment Considerations in CLL: Challenging Patient Cases

Treatment Considerations in R/R CLL - A Patient Case Study

Feat. J. N. Allan
Gynecologic
07:23
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 1 Trial of Botensilimab + Balstilimab in Patients Wit…

Feat. B. Bockorny
33:45
Dana-Farber Cancer Institute

Lynch Syndrome and Gynecologic Cancer Risk (and Risk Reduction)

Feat. M. del Carmen